Comparative Perspectives: BioFire™ FilmArray® Quality Control vs. Other Molecular Diagnostic Platforms

What “QC” means on cartridge-based multiplex PCR systems

All three systems integrate built-in (procedural) controls inside single-use cartridges/pouches and support external positive/negative controls. Under CLIA and most accreditation programs, labs must implement QC that monitors the entire testing process—and may use an IQCP (Individualized QC Plan) to rely on internal controls for daily QC if properly justified and documented. eCFR+1CDC+1Documents Cloud

• FilmArray® pouches carry two internal process controls:
  RNA Process Control (lyophilized S. pombe transcript) that is released during loading and carried through lysis → extraction → RT-PCR → HRM analysis; and PCR2 Control (a DNA target embedded in the array) verifying second-stage PCR/melt. Runs fail if either control is out-of-range. External controls are recommended per policy. MediRay

• QIAstat-Dx® cartridges include a dried MS2 bacteriophage Internal Control that is rehydrated upon sample loading and verifies resuspension, lysis, NA purification, RT and PCR end-to-end. External positive/negative controls are run per lab policy. Biotechnologie.fr

• ePlex® cartridges (RP2 panel) use system-interpreted Internal Control logic and support defined external controls; reports show PASS/FAIL/INVALID for internal control and a dedicated control report if external controls are configured. Detection uses electrochemical (eSensor®) signal probes on gold electrodes (not qPCR Ct). Elabdoc

Ease of use & runtime (hands-on vs. time-to-result)

Takeaway: FilmArray is fastest to a result; QIAstat-Dx provides granular run data (Ct/curves) many labs value for QC trend analysis; ePlex emphasizes workflow/administrative controls (e.g., QC tracking in software). bioMérieux WebsiteQIAGENDiagnostics

QC architecture—how the controls actually work

FilmArray®

• Internal: RNA Process Control (lyophilized S. pombe transcript) exercises everything from lysis to detection; PCR2 control verifies 2nd-stage PCR/HRM. The software rejects runs if control Tm drifts outside allowed windows. MediRay

• External: BioFire tech notes list compatible QC materials (e.g., MMQCI control panels) and provide guidance for Daily QC Equivalence / IQCP (e.g., CAP 20-day studies). bioMérieux WebsiteBioFire Diagnostics

• PT/EQA: BioFire publishes compatible proficiency testing material lists to support external assessments. bioMérieux Website

QIAstat-Dx®

• Internal: MS2 internal control verifies sample processing → NA extraction → RT-PCR in every cartridge. Biotechnologie.fr

• External: Third-party control panels available (e.g., MMQCI RP controls for QIAstat-Dx). mmqci.com

• Run-data: System presents Ct values/curves for review—useful for within-lab trend charts and IQCP evidence. QIAGEN

ePlex®

• Internal: Software-interpreted internal control status (PASS/FAIL/INVALID) appears on each report. External controls configurable in software with a target-level pass/fail control report. Elabdoc

• External: Roche documentation references on-board QC tracking capabilities for compliance monitoring. Diagnostics

Reproducibility levers: what helps runs agree day-to-day and site-to-site

• Built-in procedural controls reduce day-to-day variability by verifying all critical steps and automatically invalidating compromised runs (e.g., extraction failure). (FilmArray RNA Process Control + PCR2; QIAstat MS2; ePlex internal control logic). MediRayBiotechnologie.frElabdoc

• Standardized runtime and minimal hands-on reduce operator variance; FilmArray’s ~45-min and QIAstat’s ~1-h fixed cycles are typical; ePlex ~90–100 min. bioMérieux WebsiteBiotechnologie.frDiagnostics

• Published multicenter evaluations document cross-site performance—e.g., FilmArray RP2’s reduced time-to-result and QIAstat-Dx RP’s multicenter performance vs comparators. (Use as context for your verification plans.) PMC+1

Cost-effectiveness: where QC impacts your budget

Cartridge costs dominate per-test economics, so QC policies matter:

• Leverage IQCP for cartridge-based systems to justify internal-control-based daily QC once you’ve done a formal 20-day QC equivalence (CAP/CMS-aligned approach). This often reduces external control frequency (e.g., per lot, shipment, new operator) without compromising oversight. BioFire Diagnostics+1CMS

• Pick external controls that cover panel scope (MMQCI and others publish BioFire/QIAstat-Dx/ePlex-specific control panels). This minimizes wasted controls and avoids burning a full patient cartridge for rudimentary checks. bioMérieux Websitemmqci.com

• Use system tools: ePlex’s on-board QC tracking and QIAstat-Dx built-in Ct/curve review can shorten investigations and support preventive actions, saving technologist time. DiagnosticsQIAGEN

Side-by-side QC workflow snapshot

At a glance (per-run QC flow):

• FilmArray®: Load sample + buffer → pouch introduces RNA process control; instrument executes lysis/extraction/nested PCR/HRM; software validates RNA control Tm + PCR2 control; optional external controls per schedule/IQCP. MediRay

• QIAstat-Dx®: Load sample → cartridge rehydrates MS2 internal control → extraction + RT-PCR; internal control must amplify; instrument shows Ct values/curves; external controls per schedule/IQCP. Biotechnologie.frQIAGEN

• ePlex®: Pipette sample → fully automated workflow to electrochemical readout; software displays Internal Control PASS/FAIL; external controls logged with target-level pass/fail in dedicated reports. Elabdoc

Turnaround time, throughput & operational fit

• TAT: FilmArray ≈ 45 min (fastest), QIAstat-Dx ≈ ~1 h, ePlex ≈ ~90–100 min. bioMérieux WebsiteBiotechnologie.frDiagnosticsScienceDirect

• Hands-on: All are low-touch (FilmArray ~2 min; QIAstat-Dx <1 min; ePlex <1–2 min). Fewer steps = fewer pre-analytical errors. bioMérieux WebsiteQIAGENDiagnostics

• Run-data depth: QIAstat-Dx uniquely exposes Ct & curves, which some labs prefer for trend-charting and root-cause analysis; FilmArray uses HRM-based calls; ePlex uses eSensor electrochemistry. QIAGENbioMérieux WebsiteElabdoc

Why standardized QC practices are essential (and what “good” looks like)

Under CLIA Subpart K, labs must maintain a quality system with written QC policies, verification/validation, ongoing monitoring, and corrective actions. Consistent, documented QC enables inter-laboratory reproducibility and trustworthy results—especially critical when multiple sites run different platforms. eCFR+1

Essentials to standardize across sites

1. IQCP framework (if used): Same risk assessment, control plan, and quality assessment logic across instruments/sites; retain evidence (e.g., 20-day studies, trending). CDC+1BioFire Diagnostics

2. External controls: Define frequency triggers (new lot/shipment, service event, new operator) and materials (e.g., MMQCI panels matched to each platform). bioMérieux Websitemmqci.com

3. PT/EQA participation: Use CAP (or equivalent) proficiency testing for objective cross-lab comparison and to surface systematic bias. College of American Pathologists

4. Run-data trending:

   • FilmArray: monitor control Tm stability (RNA Process Control, PCR2). MediRay

   • QIAstat-Dx: chart Ct distributions for internal control and common targets. QIAGEN

   • ePlex: review internal control pass rates and external control “target pass/fail” summaries. Elabdoc

5. Documentation: Align with CDC/CMS IQCP and CAP checklist expectations so audits are straightforward. CDCDocuments Cloud

Practical recommendations (actionable, platform-agnostic)

• Adopt IQCP for cartridge systems when justified by data; anchor it with a 20-day daily-QC equivalence and ongoing quality assessment (monthly trend review). BioFire Diagnostics

• Right-size external QC:

  • Run pos/neg at receipt of new lots/shipments, after service, and for new operators; consider a reduced daily frequency if your IQCP supports it. CDC

  • Choose platform-specific control panels (BioFire/QIAstat-Dx/ePlex) for clean acceptance criteria and minimal waste. bioMérieux Websitemmqci.com

• Trend internal controls:

  • FilmArray: chart control Tm (RNA Process Control, PCR2) and investigate drift. MediRay

  • QIAstat-Dx: track MS2 Ct centerline/SD and per-target Ct distributions. Biotechnologie.frQIAGEN

  • ePlex: monitor internal control PASS rate and external control target-level pass/fail statistics. Elabdoc

• Exploit platform strengths: QIAstat’s Ct/curves assist in root-cause for weak signals; ePlex’s QC tracking simplifies compliance reporting; FilmArray’s rapid TAT reduces repeat testing queues. QIAGENDiagnosticsbioMérieux Website

• Participate in PT/EQA at least twice yearly for panel testing; harmonize acceptance thresholds across sites to maintain inter-lab reproducibility. College of American Pathologists

Bottom line

• Ease of use: All three are load-and-go; FilmArray and QIAstat-Dx are among the quickest for hands-on; ePlex emphasizes software-assisted QC tracking. bioMérieux WebsiteQIAGENDiagnostics

• Turnaround time: FilmArray (~45 min) < QIAstat-Dx (~1 h) < ePlex (~90–100 min)—but data visibility (QIAstat-Dx Ct/curves) and compliance features (ePlex QC tracking) can offset pure TAT differences depending on your lab’s priorities. bioMérieux WebsiteBiotechnologie.frDiagnostics

• Reproducibility: All employ robust internal controls; consistent IQCP, external controls, and PT/EQA are the decisive factors for cross-site reproducibility. MediRayBiotechnologie.frElabdocCDCCollege of American Pathologists

• Cost-effectiveness: Smart QC scheduling via IQCP and platform-specific control materials can lower QC-related cartridge usage while preserving high confidence in results. CDCBioFire Diagnostics

Key sources (representative)

• FilmArray: Internal controls and QC (RNA Process Control, PCR2 control), ~45-min runtime, QC/PT material lists, daily QC equivalence guidance. MediRaybioMérieux Website+2bioMérieux Website+2BioFire Diagnostics

• QIAstat-Dx: MS2 internal control (end-to-end), ~67–75 min TAT, Ct/curve visualization, FDA/press materials. Biotechnologie.frQIAGENFDA Access Data

• ePlex: Internal control reporting, external control reports, ~90–100 min TAT, system QC tracking features. ElabdocDiagnostics+1

• Standards/Regulatory: CLIA Subpart K & overview, CDC/CMS IQCP, CAP IQCP FAQ, PT programs. eCFR+1CDC+1Documents CloudCollege of American Pathologists